Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis

Abstract

Pravastatin rendered a positive reduction in BDO-induced increases in plasma bile acid concentrations and cholesterol liver content, mainly through the transcriptionally-mediated downregulation of genes involved in the synthesis of these compounds in the liver.